Breaking News
Get 55% Off 0
🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAY
CLAIM SALE
Close

Nippon India Pharma Fund - Direct Plan - Bonus Plan (0P0000XVFI)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
569.637 +0.310    +0.05%
08/11 - Closed. Currency in INR
  • Morningstar Rating:
  • Total Assets: 86.89B
Type:  Fund
Market:  India
Issuer:  Reliance Nippon Life Asset Management Ltd
ISIN:  INF204K01I27 
Asset Class:  Equity
Reliance Pharma Fund - Direct Plan - Bonus Plan 569.637 +0.310 +0.05%

0P0000XVFI Technical Analysis

 
A brief summary - strong Buy, Buy, strong sell, sell or neutral signals for the Nippon India Pharma Fund - Direct Plan - Bonus Plan fund. Access detailed technical analysis through moving averages buy/sell signals (simple and exponential for 5,10,20,50,100 and 200 periods) and common chart indicators (RSI, Stochastics, StochRSI, MACD, ADX, CCI, ROC, Williams %R, Ultimate and more) Buy, Sell, Overbought, Oversold or Neutral signals. Also - pivot points levels for Standard, Fibonacci, Camarilla, Woodie's and Demark's are supplied. All 0P0000XVFI fund Technical Studies are available in different time frames.
Summary:Strong Buy
Moving Averages:Strong BuyBuy (10)Sell (2)
Technical Indicators:Strong BuyBuy (6)Sell (2)

Pivot PointsNov 08, 2024 22:15 GMT

Name S3 S2 S1 Pivot Points R1 R2 R3
Classic 569.331 569.331 569.331 569.331 569.331 569.331 569.331
Fibonacci 569.331 569.331 569.331 569.331 569.331 569.331 569.331
Camarilla 569.331 569.331 569.331 569.331 569.331 569.331 569.331
Woodie's 569.331 569.331 569.331 569.331 569.331 569.331 569.331
DeMark's - - 569.331 569.331 569.331 - -

Technical IndicatorsNov 08, 2024 22:15 GMT

Name Value Action
RSI(14) 49.849 Neutral
STOCH(9,6) 70.713 Buy
STOCHRSI(14) 82.907 Overbought
MACD(12,26) -1.351 Sell
ADX(14) 100.000 Overbought
Williams %R -30.490 Buy
CCI(14) 53.1601 Buy
ATR(14) 3.9026 Less Volatility
Highs/Lows(14) 3.7932 Buy
Ultimate Oscillator 56.904 Buy
ROC -1.561 Sell
Bull/Bear Power(13) 1.9334 Buy

Buy: 6

Sell: 2

Neutral: 1


Summary:Strong Buy

Moving AveragesNov 08, 2024 22:15 GMT

Period Simple Exponential
MA5 568.817
Buy
568.702
Buy
MA10 566.040
Buy
568.867
Buy
MA20 570.672
Sell
569.544
Buy
MA50 573.642
Sell
565.365
Buy
MA100 548.757
Buy
549.348
Buy
MA200 510.034
Buy
510.973
Buy

Buy: 10

Sell: 2


Summary:Strong Buy

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P0000XVFI Comments

Write your thoughts about Nippon India Pharma Fund - Direct Plan - Bonus Plan
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email